Hepatic portal venous gas (HPVG) is considered to be a sign of poor prognosis in abdominal diseases and a potentially fatal condition. However, HPVG after colonic endoscopic submucosal dissection (ESD), is an even rarer complication that there is just one report of it at the moment. In this report, we present a case of HPVG and bacteremia that happened a day after colonic ESD in the descending colon. A 79‐year‐old female was referred to perform endoscopic treatment for a 40‐mm elevated tumor in the descending colon and surgery for clinical T1b cancer in the rectosigmoid colon. With a preoperative diagnosis of intramucosal carcinoma in adenoma, we performed ESD using carbon dioxide insufflation. The tumor was resected en bloc without any adverse events including perforation. On the following day, shivering and a fever of 38°C suddenly developed with no abdominal symptoms. Computed tomography revealed the presence of HPVG and gas in the middle colic vein without pneumoperitoneum. The patient was managed conservatively with fasting and intravenous antibiotic treatment. We confirmed the disappearance of the findings with computed tomography on the next day of the first computed tomography and with a colonoscope, we observed the base of ESD ulcer 5 days post‐ESD. HPVG might be treated conservatively, but it might cause more severe conditions such as air embolism, so this rare complication still needs to be thoroughly monitored.
Objectives: Paneth cell metaplasia (PCM), a metaplastic change associated with chronic inflammation in ulcerative colitis (UC), may be linked to UC‐associated neoplasia (UCAN). However, no endoscopic method currently exists for detecting PCM. This study aimed to develop and validate a novel endoscopic staining technique—CV‐SCAN—for identifying PCM and UCAN, and to explore the molecular characteristics of the stained areas. Methods: This retrospective observational study included 131 patients with UC undergoing surveillance colonoscopy. CV‐SCAN involved spraying an ultra‐diluted solution (0.006%) of crystal violet from the descending colon to the rectum. Biopsies were obtained from stained and non‐stained areas and evaluated histologically and molecularly. RNA expression profiles were analyzed via microarray and real‐time RT‐PCR. The diagnostic performance of CV‐SCAN for detecting PCM was assessed, along with its correlation with UCAN history. Results: CV‐SCAN visualized sharply demarcated, purple‐stained areas corresponding to PCM or UCAN. PCM was significantly associated with a history of UCAN. Uniform, dark staining was characteristic of PCM, while UCAN showed heterogeneous staining with small round pits. CV‐SCAN achieved a sensitivity of 81.3% and a specificity of 84.9% for PCM detection. Molecular analysis revealed upregulation of Paneth cell–specific (DEFA5, DEFA6), small intestinal (CCL25, APOC3), and UCAN‐associated (IL17RC) genes, along with downregulation of SATB2 in stained areas. Conclusions: CV‐SCAN is a novel and effective endoscopic staining method for detecting PCM and UCAN in patients with UC. It enables risk stratification through direct visualization of precancerous changes and may facilitate early detection and targeted surveillance.